Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bile salt manipulation in Crohn's disease
ISRCTN77283008Phase 2Completed
- Sponsor
- University College London
- Start
- May 2009
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01
Overview
Phase 2, open-label, single-arm trial of atorvastatin and colesevelam in Crohn's disease, sponsored by University College London. Primary endpoint: CDAI response at week 6. Started May 2009; status: completed.
02
Drugs
atorvastatincolesevelam
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on ISRCTN77283008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN77283008.